Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24


Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269.

Stella M, Giuliani M, Biolchi A, Tomei S, De Paola R, Bai X, Borrow R, Lucidarme J, La Gaetana R, Toneatto D, Pizza M, Serino L, Mori E, Giuliani MM.

Hum Vaccin Immunother. 2019 Dec 6:1-4. doi: 10.1080/21645515.2019.1688039. [Epub ahead of print]


Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules.

Biolchi A, Tomei S, Santini L, Welsch JA, Toneatto D, Gaitatzis N, Bai X, Borrow R, Giuliani MM, Mori E, Pizza M.

Hum Vaccin Immunother. 2019;15(3):725-731. doi: 10.1080/21645515.2018.1537756. Epub 2019 Jan 2.


Peptides isolated from animal venom as a platform for new therapeutics for the treatment of Alzheimer's disease.

Camargo LC, Campos GAA, Galante P, Biolchi AM, Gonçalves JC, Lopes KS, Mortari MR.

Neuropeptides. 2018 Feb;67:79-86. doi: 10.1016/j.npep.2017.11.010. Epub 2017 Nov 28. Review.


Antinociceptive properties of the mastoparan peptide Agelaia-MPI isolated from social wasps.

Gonçalves J, Rangel M, Biolchi A, Alves E, Moreira K, Silva L, Mortari M.

Toxicon. 2016 Sep 15;120:15-21. doi: 10.1016/j.toxicon.2016.07.009. Epub 2016 Jul 12.


Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined.

Biagini M, Spinsanti M, De Angelis G, Tomei S, Ferlenghi I, Scarselli M, Rigat F, Messuti N, Biolchi A, Muzzi A, Anderloni G, Brunelli B, Cartocci E, Buricchi F, Tani C, Stella M, Moschioni M, Del Tordello E, Colaprico A, Savino S, Giuliani MM, Delany I, Pizza M, Costantino P, Norais N, Rappuoli R, Masignani V.

Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2714-9. doi: 10.1073/pnas.1521142113. Epub 2016 Feb 17.


Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England.

Ladhani SN, Giuliani MM, Biolchi A, Pizza M, Beebeejaun K, Lucidarme J, Findlow J, Ramsay ME, Borrow R.

Emerg Infect Dis. 2016 Feb;22(2):309-11. doi: 10.3201/eid2202.150369.


Pharmacological Alternatives for the Treatment of Neurodegenerative Disorders: Wasp and Bee Venoms and Their Components as New Neuroactive Tools.

Silva J, Monge-Fuentes V, Gomes F, Lopes K, dos Anjos L, Campos G, Arenas C, Biolchi A, Gonçalves J, Galante P, Campos L, Mortari M.

Toxins (Basel). 2015 Aug 18;7(8):3179-209. doi: 10.3390/toxins7083179. Review.


Neuroactive compounds obtained from arthropod venoms as new therapeutic platforms for the treatment of neurological disorders.

Monge-Fuentes V, Gomes FM, Campos GA, Silva Jde C, Biolchi AM, Dos Anjos LC, Gonçalves JC, Lopes KS, Mortari MR.

J Venom Anim Toxins Incl Trop Dis. 2015 Aug 8;21:31. doi: 10.1186/s40409-015-0031-x. eCollection 2015.


A large portion of meningococcal antigen typing system-negative meningococcal strains from spain is killed by sera from adolescents and infants immunized with 4CMenB.

Abad R, Biolchi A, Moschioni M, Giuliani MM, Pizza M, Vázquez JA.

Clin Vaccine Immunol. 2015 Apr;22(4):357-60. doi: 10.1128/CVI.00669-14. Epub 2015 Jan 28.


Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives.

Whelan J, Bambini S, Biolchi A, Brunelli B, Robert-Du Ry van Beest Holle M.

Expert Rev Vaccines. 2015 May;14(5):713-36. doi: 10.1586/14760584.2015.1004317. Epub 2015 Jan 21. Review.


Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: conjugates based on core oligosaccharides.

St Michael F, Cairns CM, Filion AL, Biolchi A, Brunelli B, Giuliani M, Richards JC, Cox AD.

Glycoconj J. 2014 Jan;31(1):25-39. doi: 10.1007/s10719-013-9500-z. Epub 2013 Sep 7.


Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage.

Frosi G, Biolchi A, Lo Sapio M, Rigat F, Gilchrist S, Lucidarme J, Findlow J, Borrow R, Pizza M, Giuliani MM, Medini D.

Vaccine. 2013 Oct 9;31(43):4968-74. doi: 10.1016/j.vaccine.2013.08.006. Epub 2013 Aug 14.


Transcriptional regulation of the nadA gene in Neisseria meningitidis impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccine.

Fagnocchi L, Biolchi A, Ferlicca F, Boccadifuoco G, Brunelli B, Brier S, Norais N, Chiarot E, Bensi G, Kroll JS, Pizza M, Donnelly J, Giuliani MM, Delany I.

Infect Immun. 2013 Feb;81(2):560-9. doi: 10.1128/IAI.01085-12. Epub 2012 Dec 10.


Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1.

Brunelli B, Del Tordello E, Palumbo E, Biolchi A, Bambini S, Comanducci M, Muzzi A, Pizza M, Rappuoli R, Donnelly JJ, Giuliani MM, Serruto D.

Vaccine. 2011 Jan 29;29(5):1072-81. doi: 10.1016/j.vaccine.2010.11.064. Epub 2010 Dec 3.


Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines.

Donnelly J, Medini D, Boccadifuoco G, Biolchi A, Ward J, Frasch C, Moxon ER, Stella M, Comanducci M, Bambini S, Muzzi A, Andrews W, Chen J, Santos G, Santini L, Boucher P, Serruto D, Pizza M, Rappuoli R, Giuliani MM.

Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19490-5. doi: 10.1073/pnas.1013758107. Epub 2010 Oct 20.


Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: immunology of glycoconjugates with high carbohydrate loading.

Cox AD, St Michael F, Neelamegan D, Lacelle S, Cairns CM, Giuliani MM, Biolchi A, Hoe JC, Moxon ER, Richards JC.

Glycoconj J. 2010 Oct;27(7-9):643-8. doi: 10.1007/s10719-010-9309-y. Epub 2010 Oct 5.


Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.

Giuliani MM, Biolchi A, Serruto D, Ferlicca F, Vienken K, Oster P, Rappuoli R, Pizza M, Donnelly J.

Vaccine. 2010 Jul 12;28(31):5023-30. doi: 10.1016/j.vaccine.2010.05.014. Epub 2010 May 21.


Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans.

Serruto D, Spadafina T, Ciucchi L, Lewis LA, Ram S, Tontini M, Santini L, Biolchi A, Seib KL, Giuliani MM, Donnelly JJ, Berti F, Savino S, Scarselli M, Costantino P, Kroll JS, O'Dwyer C, Qiu J, Plaut AG, Moxon R, Rappuoli R, Pizza M, Aricò B.

Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3770-5. doi: 10.1073/pnas.0915162107. Epub 2010 Feb 3.


Structural organization of NadADelta(351-405), a recombinant MenB vaccine component, by its physico-chemical characterization at drug substance level.

Magagnoli C, Bardotti A, De Conciliis G, Galasso R, Tomei M, Campa C, Pennatini C, Cerchioni M, Fabbri B, Giannini S, Mattioli GL, Biolchi A, D'Ascenzi S, Helling F.

Vaccine. 2009 Mar 26;27(15):2156-70. doi: 10.1016/j.vaccine.2009.01.099. Epub 2009 Jan 31.


A universal vaccine for serogroup B meningococcus.

Giuliani MM, Adu-Bobie J, Comanducci M, Aricò B, Savino S, Santini L, Brunelli B, Bambini S, Biolchi A, Capecchi B, Cartocci E, Ciucchi L, Di Marcello F, Ferlicca F, Galli B, Luzzi E, Masignani V, Serruto D, Veggi D, Contorni M, Morandi M, Bartalesi A, Cinotti V, Mannucci D, Titta F, Ovidi E, Welsch JA, Granoff D, Rappuoli R, Pizza M.

Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10834-9. Epub 2006 Jul 6.


Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles.

Ferrari G, Garaguso I, Adu-Bobie J, Doro F, Taddei AR, Biolchi A, Brunelli B, Giuliani MM, Pizza M, Norais N, Grandi G.

Proteomics. 2006 Mar;6(6):1856-66.


The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies.

Giuliani MM, Santini L, Brunelli B, Biolchi A, Aricò B, Di Marcello F, Cartocci E, Comanducci M, Masignani V, Lozzi L, Savino S, Scarselli M, Rappuoli R, Pizza M.

Infect Immun. 2005 Feb;73(2):1151-60.


The human TruB family of pseudouridine synthase genes, including the Dyskeratosis Congenita 1 gene and the novel member TRUB1.

Zucchini C, Strippoli P, Biolchi A, Solmi R, Lenzi L, D'Addabbo P, Carinci P, Valvassori L.

Int J Mol Med. 2003 Jun;11(6):697-704.


Expression profile of epidermal differentiation complex genes in normal and anal cancer cells.

Zucchini C, Biolchi A, Strippoli P, Solmi R, Rosati G, Del Governatore M, Milano E, Ugolini G, Salfi N, Farina A, Caira A, Zanotti S, Carinci P, Valvassori L.

Int J Oncol. 2001 Dec;19(6):1133-41.


Supplemental Content

Loading ...
Support Center